A randomized, double-blind, placebo-controlled clinical study to assess safety and clinical activity of OTO-104 given as a single intratympanic injection in patients with unilateral M?ni?re's disease.

A randomized, double-blind, placebo-controlled clinical study to assess safety and clinical activity of OTO-104 given as a single intratympanic injection in patients with unilateral M?ni?re's disease. Otol Neurotol. 2012 Sep; 33(7):1257-65.

View in: PubMed